INTRODUCTION
All laboratory strains of mice contain a wealth of endogenous proviruses, many of them in multiple copies (Coffin, 1982) . A few replication-competent viruses are spontaneously expressed or can be induced from fibroblast cultures and have been characterized. Among these proviruses are a number of ecotropic (E-MuLV) and xenotropic (X-MuLV) viruses . Expression of some C-type retroviruses results in the spontaneous thymic leukaemias which characterize certain strains of mice such as AKR and HRS (Lilly & Pincus, 1973; Green et al., 1980) . Dual-tropic host-range viruses, which are capable of giving rise to cytopathic foci on mink cells (hence called MCF viruses), the foci being formed by recombination between an E-MuLV and one or more as yet poorly defined endogenous X-MuLV-like viruses, are believed to play a crucial role in the leukaemogenic process (Hartley et al., 1977; Cloyd et al., 1980) . Similarly, the thymic leukaemia induced by Moloney leukaemia virus is thought to involve recombination with an endogenous virus (van der Putten et al., 1981) . However, little is known about the virological steps leading to the generation of recombinant viruses, in particular the inheritance and expression of the non-ecotropic viruses. In addition, the mechanism by which recombinant viruses induce disease remains obscure. Evidence has been presented that cellular oncogenes can become activated by promoter insertion following virus integration (Hayward et al., 1981; Payne et al., 1982) . Furthermore, immunological mechanisms have been invoked (McGrath & Weissman, 1979; Moroni et al., 1980; Ihle & Lee, 1982) .
To examine the possible origin of the leukaemogenic recombinant retroviruses, we have continued to investigate the expression of endogenous viruses in primary mouse lymphocyte t Present address: Cancer Research Center, Tufts University, School of Medicine, 136 Harrison Ave., Boston, Massachusetts 02111, U.S.A. 0022-1317/84/0000-5740 $02.00 © 1984 SGM cultures. Previously, we and others have shown that cultured mouse spleen cells stimulated with the B-cell mitogen lipopolysaccharide (LPS) release X-MuLV Greenberger et al., 1975) and that bromodeoxyuridine (BUdR), a potent virus inducer in fibroblasts (Lowy et al., 1971 ) amplifies X-MuLV production Phillips et al., 1976; Stoye & Moroni, 1983) . This induction is controlled by a genetic locus, Bxv-1, mapping on chromosome I (Kozak & Stoye & Moroni, 1983) . We have shown that defective retroviruses can also be detected in lymphocyte cultures derived from different strains of mice. Stimulated 129/J lymphocytes release defective particles which lack reverse transcriptase activity but which can be assayed serologically (Jongstra & Moroni, 1981) . BALB/c lymphocytes produce, in addition to X-MuLV, a non-infectious, reverse transcriptase-positive retrovirus we have termed Bdv (Stoye & Moroni, 1983) . Experiments to characterize further the variety and extent of endogenous retrovirus expression in lymphocytes treated with LPS and BUdR and to investigate the possibility of interaction with infecting ecotropic viruses are the subject of this report.
METHODS
Cell lines and viruses. The mink lung fibroblast line CCL-64 and rat XC cells were obtained from N. Teich (Imperial Cancer Research Fund Laboratories, London, U.K.) and NIH-3T3 cells came from R. Weinberg (Massachusetts Institute of Technology, Cambridge, Mass., U.S.A.). The mink cell line, F648.1 which is a sarcoma virus-positive, leukaemia virus-negative (S ÷ L-) line came from P. Peebles (National Cancer Institute, Bethesda, Md., U.S.A). Moloney sarcoma virus (MSV) can be rescued from this phenotypically non-transformed line by infection with X-MuLV; this forms the basis of a focus assay for X-MuLV (Peebles, 1975) . Aliquots of molecularly cloned NB-tropic Friend leukaemia virus (F-MuLV) (Oliff et al., 1980) were obtained from 0.45 ~tmfiltered supernatants of NIH-57 cells (J. F. Conscience, Friedrich Miescher-Institut, Basel) and stored frozen at -80 °C. The stock F-MuLV had a titre of 8 x 106 p.f.u./ml in the XC assay. Pseudotype viruses are described below. Cell lines were grown in Dulbecco's modified medium supplemented with 10~ foetal calf serum (FCS).
Mice. One-to 2-month-old BALB/c, NFS/N and 129 mice came from the Ciba-Geigy animal breeding facility (Sisseln, Switzerland). AKR mice of a similar age were supplied by Bomholtgard (Ry, Denmark). Mice were used within 3 months of delivery.
Spleen cell cultures. Aseptically prepared spleen cell suspensions were cultured in flasks for 3 days at 2.5 x 106 viable nucleated cells per ml in RPMI 1640 medium supplemented with 8 ~ FCS (Gibco, batch no. K764101S), 20 mM-HEPES, 1.6 mM-glutamine, 100 IU/ml penicillin and 100 lxg/ml streptomycin. LPS (LPS-W from Escherichia coli 011 l-B4; Difco) was added to 16 ~tg/ml at the start of culturing, BUdR (Calbiochem) to 5 p.g/ml 24 h later. Incubation was at 37 °C in a 93~ air/7~ CO2 incubator.
Spleen cell infection. Viable 1-day cultured spleen cells were prepared by flotation on 35 ~ bovine serum albumin (BSA) (Path-O-Cyte, Pentex; Miles Laboratories) as previously described (Jongstra & Moroni, 1981) . The spleen cells (5 x 106/ml) were infected with F-MuLV at a multiplicity of infection (m.o.i.) of 0-8 in the presence of 15 ~tg/ml Polybrene (Aldrich) for 1 h at 37 °C, washed and recultured in the spleen cell medium described above for a further 2 days after adding LPS and BUdR as appropriate. The same protocol was followed for the infection of spleen cells with other viruses described in Results.
Infectivity assays for MuLV. Ecotropic virus was determined using the UV-XC assay (Rowe et al., 1970) . NIH-3T3 cells, plated 1 day previously at 105 cells per 60 mm dish, were infected for I h with 1 ml virus dilution or virusproducing cell suspension containing 15 p.g/ml Polybrene. After washing, the NIH-3T3 ceils were cultured for 5 days with one medium change on day 3, prior to irradiation and the addition of 106 XC cells in 4 ml medium. Two days later, clear plaques were counted in methanol-fixed, Giemsa-stained cultures. Triplicate determinations were performed. Results are expressed as p.f.u./ml or p.f.u./106 cells.
Xenotropic virus was assayed using the focus induction assay described by Peebles (1975) . Infection of mink S÷L cells with a replication-competent xenotropic virus results in focus formation by rescue of the MSV genome and subsequent infection and transformation of neighbouring cells (Ishimoto, 1980) . Mink S ~ L-cells (105 ) were plated onto 60 mm tissue culture dishes in 4 ml medium. The following day, medium was removed and 1 ml virus inoculum (either virus-producing spleen cells or cell-free supernatants from virus-producing cells) containing 15 txg/ml Polybrene was added and cultures returned to the incubator. After 1 h the virus inoculum was removed, the S ÷ L-cells washed once and then re-fed with 4 ml medium. Subsequently, the medium was changed once, 3 days after infection, prior to scoring foci microscopically on fixed ceils 6 days after infection. Triplicate determinations were performed. Results with cell-free supernatants are expressed as f.f.u./ml, with spleen cells as f.f.u./106 cells.
Detection ofpseudotype MuLVs. To detect production of F-MuLV with a X-MuLV coat [F-MuLV(X-MuLV)], 1 ml of spleen cell suspension previously infected with F-MuLV was added in the presence of 15 lag/ml Polybrene to mink S+L -cells plated 1 day previously at 10 s per 60 mm dish. After 1 h the spleen cells were removed, 4 ml medium added and the S+L -cells cultured for a further 6 days with medium changes at days 2 and 4 for the enumeration of X-MuLV-producing spleen cells. In addition, the day-4 culture medium was tested for rescue of MSV from the S ÷ L-cells by F-MuLV. One ml aliquots were made 15 p.g/ml in Polybrene and used to infect NIH-3T3 cells plated 1 day previously at 10 s per 60 mm dish. After removal of the virus inoculum and addition of 4 ml fresh medium, the cells were cultured for 6 days with two medium changes before counting MSV-induced foci under low magnification with unfixed cells.
X-MuLV with an ecotropic virus coat [X-MuLV(F-MuLV)] was detected similarly, by infecting first NIH-3T3 ceils and then testing 4-day culture supernatants for xenotropic virus on mink S+L -cells.
Reverse transcriptase assay. Spleen cell culture supernatants were clarified, retrovirus was concentrated by ultracentrifugation and reverse transcriptase activity was determined using oligo(dT), poly(rA) as template-primer as previously described with one minor modification: 0.12~ Nonidet P40 was used rather than 0.1 ~. Duplicate determinations were performed and results are expressed as pmol TMP incorporated in 60 rain by virus concentrated from 1 ml of culture supernatant.
RESULTS

Expression of different endogenous retroviruses in mouse lymphocytes
To survey the variety of endogenous retroviruses induced in stimulated lymphocyte cultures, we have examined the pattern of mitogen-induced retrovirus production in four strains of mice, two from which X-MuLV can be induced by BUdR in fibroblast cultures, i.e. AKR and BALB/c, and two non-inducible, i.e. 129 and NFS/N (Levy, 1978) . Both reverse transcriptase measurements and an infectious centre S + L-assay for cells producing X-MuLV were used to measure retrovirus production in 3-day spleen cell cultures. BUdR increased the number of X-MuLV infectious centres in BALB/c by a factor of around 100, whereas it increased the amount of reverse transcriptase by a factor of only about 10 (Table 1) . This suggested the induction of at least two viruses from stimulated lymphocytes: one being defective and induced predominantly by LPS, and one being replication-competent and induced by BUdR. We have recently confirmed this deduction by genetic analysis which showed that two viruses are produced: one (X-MuLV) controlled by Bxv-1 and the second a reverse transcriptase-positive, defective virus controlled by a locus we have termed Bdv-1 (Stoye & Moroni, 1983) .
In accordance with previous data, 129 mice produce no detectable signs of retrovirus using these assays (Table 1 ) or in co-cultivation assays (data not shown). In contrast to the results of Phillips et al. (1977) we could not detect infectious X-MuLV production by stimulated NFS/N lymphocytes either by the infectious centre assay (Table 1) or by more sensitive co-cultivation techniques (data not shown). However, NFS/N lymphocytes did spontaneously produce low levels of reverse transcriptase, and LPS stimulated reverse transcriptase production to levels Mice BALB/c 129 NFS/N AKR Mice BALB/c 129 NFS/N AKR higher than those observed in BALB/c cultures (Table 1) . Thus it appears that NFS/N cells also produce a defective retrovirus which can be distinguished from the 129 virus (Jongstra & Moroni, 198 l) by the presence of reverse transcriptase. BUdR treatment appeared to inhibit the production of this virus.
Virus induction from spleen cells of AKR mice was also examined in these experiments since BUdR had been shown not to increase the amount of reverse transcriptase in such cultures (Schumann & Moroni, 1977) . This result was confirmed (Table 1) . However, the S+L -assay data did show that BUdR was amplifying xenotropic virus production in LPS-treated cultures. Since cells from many AKR tissues spontaneously produce ecotropic virus it seems possible that the decrease in reverse transcriptase activity could be accounted for by an inhibition of spontaneous ecotropic virus release. To test this possibility, ecotropic virus production from AKR mice was measured using the XC assay. NIH-3T3 cells were treated with cells or supernatants from 3-day stimulated AKR cultures. Five days later, the NIH-3T3 cells were irradiated, XC cells added, and plaques scored 2 days later. BUdR clearly inhibited ecotropic virus production in both control and LPS-treated cultures ( Table 2 ). Spleen cells from BALB/c mice were also tested in these experiments; however, no plaques were observed (data not shown) indicating that no N-tropic ecotropic virus is produced by LPS-or LPS/BUdR-treated BALB/c lymphocytes.
These data indicate that a number of distinguishable retroviruses in addition to the previously known ones can be induced from murine lymphocytes treated with LPS and BUdR. However, the two agents have different effects on their expression. With all the strains of mice, LPS treatment leads to induction or amplification of virus expression. BUdR, on the other hand, can have two opposing effects: either amplification, as in the case of X-MuLV expression in AKR and BALB/c lymphocytes or inhibition, as with the apparently spontaneously expressed E-MuLV from AKR and the defective virus from NFS/N.
Interactions between induced endogenous and infecting exogenous retroviruses in stimulated
lymphocytes Xenotropic virus cannot be induced from NFS/N or 129 mice even though stimulated lymphocytes from each strain release defective viral particles. These non-infectious particles are most probably the products of incomplete proviruses. However, these mice might contain complete provirus alleles similar to those present in BALB/c, which do not yield infectious viruses following induction owing to faulty, host cell-controlled virus maturation. If the latter possibility is correct, then superinfecting exogenous viruses should replicate poorly in 129 or NFS/N spleen cells when compared to cells from BALB/c or AKR.
To test this possibility we chose an NB-tropic F-MuLV for superinfection studies. This virus should replicate equally well in BALB/c (Fv-1 b) and AKR, N FS/N and 129 (Fv-1 n) cells. Viable 1-day cultures of spleen cells from BALB/c and 129 mice, purified on BSA gradients, were infected with F-MuLV at a m.o.i, of 0.8 in the presence of 15 p.g/ml Polybrene. Two days later, ecotropic virus infectious centres in control, LPS-and LPS/BUdR-treated cells were assayed using the XC assay. F-MuLV was found to replicate equally well in BALB/c and 129 cells (Table  3) . Maximum levels of virus production were seen in LPS-stimulated cells, confirming the conclusion of Ruddle et al. (1976) that spleen cell proliferation is required for virus replication. As in the case of spontaneous E-MuLV production by AKR lymphocytes, BUdR inhibited F-MuLV replication. Higher numbers of infected spleen cells were not detected upon longer culturing of the F-MuLV-infected lymphocytes (data not shown). Similar results were obtained with infected NFS/N cells (data not shown).
Since E-MuLV replicates equally well in 129 and BALB/c cells host cell restrictions on induced virus expression seems unlikely. More probably, defective provirus encodes the defective particles produced by induced 129 cells. However, since F-MuLV only infects a relatively small percentage of the heterogeneous population of stimulated lymphocytes present (Table 3) , it might be argued that the cells that are infected by F-MuLV are different to those which produce X-MuLV. In addition, subtle differences between the F-MuLV and X-MuLV genomes might result in differences between, for instance, the post-transcriptional processing of 3-day AKR spleen cell cultures were tested for N-tropic virus production using the two RNAs. Thus, ecotropic virus replication would be no indication that xenotropic virus would replicate in the same cells. To meet these criticisms we wanted to show that F-MuLV does replicate in the cells producing X-MuLV and that X-MuLV will replicate in lymphocytes.
Additionally we wanted to examine whether the defective retroviruses could be rescued by F-MuLV. The host range of E-MuLV and X-MuLV is determined by their envelope glycoprotein. Mouse cells simultaneously producing both E-MuLV and X-MuLV produce, in addition, the pseudotype viruses E-MuLV(X-MuLV) and X-MuLV(E-MuLV) (Besmer & Baltimore, 1977; Levy, 1977) . If infection of stimulated BALB/c cells with F-MuLV resulted in the formation of F-MuLV(X-MuLV) and X-MuLV(F-MuLV), this would show that F-MuLV was replicating in the cell from which xenotropic virus was induced. In addition, the X-MuLV(F-MuLV) generated in this way could be used in infection experiments to test whether X-MuLV can replicate in stimulated 129 cells.
Infection of LPS-and LPS/BUdR-treated BALB/c and AKR cells did result in the formation of F-MuLV(X-MuLV) as measured by the appearance of foci on NIH-3T3 cells following passage through mink S ÷ L-cells (Table 4 ). Pseudotype formation was limited by the levels of xenotropic virus expression, since many more foci were seen on NIH-3T3 cells following infection of LPS/BUdR-treated cells than with LPS-treated cells (Table 4) , even though BUdR inhibits F-MuLV replication (Table 3 ). In non-superinfected AKR cells, some phenotypic mixing occurs, suggesting either that AKR cells induced to make xenotropic virus also spontaneously express ecotropic virus or that spontaneously produced ecotropic virus infects cells induced to make xenotropic virus. The reason for the higher number of foci seen on S ÷ Lcells, on superinfected BALB/c, and LPS/BUdR-treated cells compared to non-superinfected cells is not known. Since the assay appeared to measure pseudotype formation well, NFS/N and 129 cells were also assayed for their ability to provide xenotropic envelope glycoprotein for superinfecting F-MuLV. This proved not to be the case (data not shown). Furthermore, in experiments using spleen cells from [(BALB/c x 129) x 129] x 129 second backcross mice, 50 ~ of which contain the Bdv-1 locus, no evidence was seen for F-MuLV(X-MuLV) formation (data not shown). Either the viral antigen induced in spleen cells from these mice do not include functional xenotropic env glycoprotein or F-MuLV is replicating in cells other than those expressing the viral antigens.
F-MuLV superinfection of xenotropic virus-producing cells should also lead to the formation of xenotropic virus with an ecotropic virus coat. This virus could then infect NIH-3T3 cells. Although spread of xenotropic virus could not occur, the supernatants of these cultures should contain this virus. Supernatants of NIH-3T3 cells, treated with F-MuLV-superinfected LPSstimulated spleen cells, were assayed for xenotropic virus by the S+L -assay. Again, only BALB/c and AKR spleen cells showed phenotypic mixing between induced and superinfecting viruses (Table 5 ). F-MuLV failed to rescue a xenotropic virus genome from NFS/N or 129 cells * One-day stimulated spleen cells were infected with F-MuLV (m.o.i. 0-8), re-cultured for 2 days and then added to S ÷ L-cells for 1 h. The S ÷ L-cells were re-cultured for a further 6 days for the estimation of xenotropic virusproducing spleen cells. Four days after S ÷ L-cell infection, 1 ml of supernatant was taken for assaying MSV (F-MuLV) on NIH-3T3 cells. Mean of two (AKR) or three experiments (BALB/c). Table 6 , F-MuLV-infected spleen cells were added briefly to NIH-3T3 cells. Four days later, I ml from NIH-3T3 cell supernatant was added to S+L -cells to test for xenotropic virus.
(data not shown). Supernatants from NIH-3T3 cells infected with F-MuLV-treated AKR and BALB/c cells were also tested for the presence of recombinant MCF viruses on CCL-64 cells. However, no cytopathic foci were seen. Similarly, the absence of foci on S+L -cells in the N FS/N and 129 groups argues against the generation of recombinant viruses following F-MuLV infection of NFS/N and 129 cells. However, the occasional generation of very weakly cytopathic Table 1  129 gag +, pol-. env ÷ Induction Amplification Jongstra & Moroni (1981) recombinant viruses cannot be excluded. Thus, F-MuLV pseudotype formation cannot be used to characterize or rescue the defective viruses induced in spleen cells from NFS/N, 129 or Bvd-l-positive mice. However, X-MuLV(F-MuLV) was produced following superinfection of LPS/BUdR-treated BALB/c lymphocytes and this virus can be used to test whether xenotropic virus will replicate equally well in BALB/c and 129 cells. A supernatant taken from NIH-3T3 cells treated 4 days previously with F-MuLV-superinfected, LPS/BUdR-stimulated BALB/c cells contains X-MuLV(F-MuLV) and F-MuLV(X-MuLV) in addition to F-MuLV and X-MuLV. Testing of this supernatant on NIH-3T3 cells, followed by assaying for X-MuLV on S÷L -cells, indicated that the supernatant had a titre of approximately 103 infectious units of X-MuLV(F-MuLV) per ml. 107 viable BALB/c or 129 spleen cells, purified after 1 day in culture, were infected with 2 ml of this supernatant for 2 h in the presence of 15 ~tg/ml Polybrene; the spleen cells were then re-cultured for 2 days prior to assaying for xenotropic virus infectious centres with the S+L -assay. X-MuLV replicated equally well in LPS-treated BALB/c and 129 spleen cells (Table 6 ). BUdR treatment inhibits the replication of the superinfecting virus. Strain 129 cells treated with the supernatant of a permanent mink line producing X-MuLV (about 104 units of X-MuLV/ml) did not give any S ÷ L-foci (data not shown), showing that xenotropic virus cannot infect mouse lymphocytes. Taken together, these data imply that the defective particle produced by 129 and NFS/N cells results from an incomplete provirus rather than faulty host-controlled virus maturation. J. P. STOYE AND CH. MORONI DISCUSSION A number of different viruses are expressed in stimulated primary lymphocyte cultures. Table  7 summarizes some of the properties of the retroviruses we have detected in such cultures. Viral gag and env proteins are induced in mitogen-stimulated 129 spleen cultures; in addition, the cells release a viral particle containing p30 (Jongstra & Moroni, 1981) . NFS/N cultures release a reverse transcriptase-positive, non-infectious particle (Table 1) ; we have not yet analysed these particles for the presence of viral gag and env proteins. BALB/c cultures release at least two different retroviruses, one the previously characterized Bxv (Kozak & Rowe, 1980) the other a reverse transcriptase-positive, non-infectious virus, which we have termed Bdv (Stoye & Moroni, 1983) . Stimulated AKR cultures release infectious ecotropic and xenotropic viruses ( Table 2 ) which appear to be controlled by different mechanisms since BUdR has opposing effects on their expression. The two reverse transcriptase-positive, non-infectious retroviruses are probably distinct and non-allelic, since BUdR inhibits LPS induction of the NFS/N virus (Table 1) while it weakly amplifies LPS induction of Bdv (Stoye & Moroni, 1983) . Since BALB/c-and AKR-derived cultures release complete viruses, we have not yet been able to determine whether they also release, say, the 129 virus.
Using a biological approach, we wished to investigate the nature of genetic loci specifying the defective viruses produced by 129, NFS/N and BALB/c mice. Previous studies of retrovirus induction from murine cells have indicated that the genetic loci controlling virus expression are proviral genomes (Chattopadhyay et al., 1975) . Similarly, segregating phenotypes of complete and defective avian retrovirus expression have been directly correlated with the presence or absence of defined full-length or partial proviruses (Astrin et al., 1980) . By analogy, defective viruses found in lymphocyte cultures would most likely be encoded by distinct defective proviruses. To test an alternative possibility, i.e. that faulty, cellular gene-controlled, virus maturation leads to defective retrovirus production in lymphocyte cultures from different strains, we compared the capacity of spleen ceils from different strains to support replication of an infecting virus. The superinfection experiments apparently rule out this possibility, further supporting the hypothesis that the defective viruses are encoded by defective proviruses.
It seems likely that endogenous retroviruses which are induced from lymphocytes proliferating and differentiating in vitro following mitogenic stimulation are expressed because they are integrated within chromosomal regions that are specifically activated in the course of Bcell differentiation (J. P. Stoye & C. Moroni, unpublished observation) . Assuming that mitogenic stimulation provides an accurate model for antigenic stimulation, it appears likely that the same retroviruses are expressed in vivo during an immune response, and are thus candidate parental viruses for the dual-tropic viruses isolated from leukaemic mice. The observation that AKR cultures produce pseudotypes between X-MuLV and E-MuLV in the absence of F-MuLV superinfection suggests that this process may occur fairly frequently in vivo even in young animals, since high levels of ecotropic virus are expressed from birth (Lilly & Pincus, 1973) . However, this does not seem to lead to the formation of dual-tropic retroviruses, since they have only been isolated from older pre-leukaemic mice (Hartley et al., 1977) . A variety of biochemical techniques have been used to show that Bxv is not involved in the generation of pathogenic MCF viruses (Green et al., 1980; Chattopadhyay et al., 1981) . The non-ecotropic parental viruses have not been isolated and may well be defective. Even though we have failed to demonstrate phenotypic mixing between ecotropic virus and the defective viruses in lymphocyte cultures it remains possible that this occasionally occurs in vivo and that recombination leading to MCF viruses follows. To test this hypothesis it will be necessary to characterize biochemically the RNA and proteins of the defective viruses.
Primary spleen cell cultures do not yield sufficient virus for biochemical analysis of the defective viruses. For this purpose it will be necessary to obtain permanent virus-producing cell lines. Two different approaches might be used to achieve this goal, either to immortalize the spleen cells producing the defective viruses or to transfer the genetic information for the defective virus to a permanent cell line by, for instance, rescuing with a competent helper. Thus, it was disappointing that no pseudotypes were seen after F-MuLV infection of spleen cells from NFS/N, 129 or Bdv-l-positive, Bxv-l-negative mice. Thus, rescue does not seem a feasible method of obtaining permanent cell lines. Alternatively, it might be possible to introduce the defective viruses into fibroblasts using inactivated Sendai virus or polyethylene glycol fusion (Weiss, 1969) , although this approach would not be expected to work with defectives such as the 129 virus which lack functional pol.
For a further analysis of the induced defective viruses as well as of the cellular factors involved in virus induction it would be desirable to immortalize the mitogen-stimulated B-ceUs. A preliminary attempt with MSV and Abelson leukaemia virus failed, even though replication of the transforming viruses in the X-MuLV-producing cells could be demonstrated by the appearance of viruses capable of transforming mink ceils (data not shown). Another approach to immortalization of the virus-producing cell lines would be to utilize cell fusion. If defective virus production is a property of differentiated late B-cells, it seems not unreasonable to expect hybridomas to produce defective virus in addition to antibody. Preliminary results indicate that this is the case (J. P. Stoye & $. Alkan, unpublished data) and that certain hybridomas produce sufficient defective retrovirus to permit biochemical characterization.
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